NO20043548L - Anvendelse av flerumettede katoner for behandling av psoriasis - Google Patents

Anvendelse av flerumettede katoner for behandling av psoriasis

Info

Publication number
NO20043548L
NO20043548L NO20043548A NO20043548A NO20043548L NO 20043548 L NO20043548 L NO 20043548L NO 20043548 A NO20043548 A NO 20043548A NO 20043548 A NO20043548 A NO 20043548A NO 20043548 L NO20043548 L NO 20043548L
Authority
NO
Norway
Prior art keywords
psoriasis
treatment
group
polyunsaturated
cotton
Prior art date
Application number
NO20043548A
Other languages
English (en)
Other versions
NO334413B1 (no
Inventor
Berit Johansen
Marit Anthonsen
Wenche Sjursen
Anne Kristen Holmeide
Lars Skattebol
Original Assignee
Avexxin As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avexxin As filed Critical Avexxin As
Publication of NO20043548L publication Critical patent/NO20043548L/no
Publication of NO334413B1 publication Critical patent/NO334413B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20043548A 2002-01-29 2004-08-25 Flerumettede ketoner ved fremstilling av medikamenter for behandling av psoriasis samt farmasøytisk preparat omfattende samme NO334413B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0202002.2A GB0202002D0 (en) 2002-01-29 2002-01-29 Use
PCT/GB2003/000364 WO2003063878A1 (en) 2002-01-29 2003-01-29 Use of polyunsaturated ketones for the treatment of psoriasis

Publications (2)

Publication Number Publication Date
NO20043548L true NO20043548L (no) 2004-08-25
NO334413B1 NO334413B1 (no) 2014-02-24

Family

ID=9929945

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043548A NO334413B1 (no) 2002-01-29 2004-08-25 Flerumettede ketoner ved fremstilling av medikamenter for behandling av psoriasis samt farmasøytisk preparat omfattende samme

Country Status (14)

Country Link
US (4) US7687543B2 (no)
EP (1) EP1469859B1 (no)
JP (1) JP4608214B2 (no)
KR (1) KR100874505B1 (no)
CN (2) CN101849929A (no)
AT (1) ATE535245T1 (no)
AU (1) AU2003206999B2 (no)
CA (1) CA2473687C (no)
DK (1) DK1469859T3 (no)
ES (1) ES2378303T3 (no)
GB (1) GB0202002D0 (no)
NO (1) NO334413B1 (no)
PT (1) PT1469859E (no)
WO (1) WO2003063878A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248798A1 (en) * 2009-05-08 2010-11-10 Pronova BioPharma Norge AS Novel lipid compounds
GB0909643D0 (en) * 2009-06-04 2009-07-22 Avexxin As Glomerulonephritis treatment
AU2010302584B2 (en) * 2009-10-02 2015-09-10 Avexxin As Anti inflammatory 2-oxothiazoles and 2 -oxooxazoles
GB201014633D0 (en) * 2010-09-02 2010-10-13 Avexxin As Rheumatoid arthritis treatment
MX350720B (es) 2010-11-05 2017-09-14 Pronova Biopharma Norge As Metodos de tratamiento usando compuestos lipidos.
GB201205394D0 (en) 2012-03-27 2012-05-09 Adlens Ltd Improvements in or relating to deformable non-round membrane assemblies
GB201221329D0 (en) * 2012-11-27 2013-01-09 Avexxin As Dermatitis treatment
KR102268357B1 (ko) 2013-01-29 2021-06-23 아벡신 에이에스 항염증성 및 항종양성 2-옥소티아졸 및 2-옥소티오펜 화합물
EP2961384B1 (en) 2013-02-28 2019-08-28 Basf As A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
GB201313238D0 (en) 2013-07-24 2013-09-04 Avexxin As Process for the preparation of a polyunsaturated ketone compound
GB201409363D0 (en) * 2014-05-27 2014-07-09 Avexxin As Skin cancer treatment
GB201413695D0 (en) 2014-08-01 2014-09-17 Avexxin As Compound
GB201501144D0 (en) 2015-01-23 2015-03-11 Avexxin As Process for the preparation of a polyunsaturated ketone compound
JP6784696B2 (ja) 2015-04-28 2020-11-11 プロノヴァ バイオファーマ ノルゲ エーエス 硫黄を含有する構造的に強化された脂肪酸の非アルコール性脂肪性肝炎の予防及び／又は治療のための使用
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
GB201604318D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
AU2017272891B2 (en) * 2016-06-03 2020-05-07 Avexxin As Combination therapy comprising a polyunsaturated ketone and a corticosteroid
CN109310770A (zh) * 2016-06-03 2019-02-05 埃维克辛公司 包含多不饱和酮和钙调磷酸酶抑制剂的联合疗法
GB201609735D0 (en) * 2016-06-03 2016-07-20 Avexxin As Combination therapy
CA3025696A1 (en) * 2016-06-03 2017-12-07 Avexxin As Combination therapy comprising a polyunsaturated ketone and a secosteroid
CN109789111B (zh) * 2016-09-21 2021-11-16 埃维克辛公司 药物组合物
EP3638221B1 (en) * 2017-06-16 2021-09-29 Avexxin AS Compositions and methods for treatment of a fibrotic disease
US11925614B2 (en) 2017-12-06 2024-03-12 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
GB201807892D0 (en) 2018-05-15 2018-06-27 Avexxin As Processes in the preparation of polyunsaturated ketone compounds
GB202020843D0 (en) 2020-12-31 2021-02-17 Coegin Pharma Ab Actinic keratosis treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09268153A (ja) * 1996-04-02 1997-10-14 Sagami Chem Res Center トリフルオロメチルケトン誘導体及びホスホリパーゼａ２阻害剤
CA2304503A1 (en) * 1997-09-23 1999-04-01 Graham Johnson Selective cpla2 inhibitors
JPH11199493A (ja) * 1997-11-13 1999-07-27 Nof Corp 皮膚外用剤組成物
US7605149B1 (en) * 1998-07-13 2009-10-20 University Of South Florida Modulation of the phospholipase A2 pathway as a therapeutic
US20020165119A1 (en) 2001-01-31 2002-11-07 Alan Leff Method of treating inflammatory conditions by inhibiting cytosolic phospholipase A2
EP1243524A3 (en) * 2001-03-16 2004-04-07 Pfizer Products Inc. Pharmaceutical kit for oxygen-sensitive drugs
US20040111957A1 (en) * 2002-12-13 2004-06-17 Filippini Brian B. Water blended fuel composition

Also Published As

Publication number Publication date
US7687543B2 (en) 2010-03-30
US8524776B2 (en) 2013-09-03
CA2473687C (en) 2011-04-12
ES2378303T3 (es) 2012-04-11
EP1469859B1 (en) 2011-11-30
JP4608214B2 (ja) 2011-01-12
NO334413B1 (no) 2014-02-24
US9375409B2 (en) 2016-06-28
PT1469859E (pt) 2012-03-06
JP2005518419A (ja) 2005-06-23
ATE535245T1 (de) 2011-12-15
KR20040089127A (ko) 2004-10-20
US8865768B2 (en) 2014-10-21
DK1469859T3 (da) 2012-03-19
US20130324613A1 (en) 2013-12-05
AU2003206999B2 (en) 2007-12-13
CN101849929A (zh) 2010-10-06
US20150202165A1 (en) 2015-07-23
WO2003063878A1 (en) 2003-08-07
GB0202002D0 (en) 2002-03-13
CA2473687A1 (en) 2003-08-07
KR100874505B1 (ko) 2008-12-18
US20050165116A1 (en) 2005-07-28
EP1469859A1 (en) 2004-10-27
CN1678323A (zh) 2005-10-05
US20100152293A1 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
NO20043548L (no) Anvendelse av flerumettede katoner for behandling av psoriasis
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
ATE539751T1 (de) Verwendung von brimonidine zur behandlung von stress assoziierten zuständen
DK1227820T3 (da) Oligosaccharidaldonsyrer og topisk anvendelse deraf
UY28081A1 (es) Administracinn combinada de una indolinona con un agente quimioterapcutico para trastornos de proliferacinn celular
ATE355056T1 (de) Jasmonate enthaltende therapeutische zusammensetzungen für die behandlung von krebs
DE60026152D1 (de) Verwendung von stearidonsäure zur herstellung eines arzneimittels für die behandlung oder vorbeugung von krebs
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
ATE539749T1 (de) Dextromethorphan für die behandlung von akne
SE0300971D0 (sv) Nitric oxide in treatment of inflammation
IS6621A (is) Þíenódíbensóasúlen efnasambönd sem hindrar fyrir æxlisdrepþátt
DE602004015406D1 (de) Verwendung von 3-methoxy-pregnenolon bei der herstellung eines arzneimittels zur behandlung von neurodegenerativen erkrankungen
DE602004023762D1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren
RU2007138263A (ru) Противовоспалительные соединения
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
UY27772A1 (es) Inhibidores triariloxiariloxipirimidin-2,4,6- triona de metaloproteinasa.
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
SE0004101D0 (sv) New use
DE60016181D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
DE60230155D1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
HUP0204551A2 (hu) Eljárás a pikkelysömör kezelésére
SE0301885D0 (sv) New use IV
DE60309465D1 (de) Behandlung oder prävention von urogenitaler atrophie und deren symptomen bei frauen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees